The distinctive patterns of capabilities accumulation and inter-firm heterogeneity: The case of the Spanish pharmaceutical industry

Industrial and Corporate Change

Volumn 11, Issue 4, 2002, Pages 847-874

  D'Este, Pablo ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INDUSTRIAL PERFORMANCE; PERFORMANCE ASSESSMENT; PHARMACEUTICAL INDUSTRY; RESEARCH AND DEVELOPMENT;

SPAIN;

EID: 0036691144     PISSN: 09606491     EISSN: None     Source Type: Journal    
DOI: 10.1093/icc/11.4.847     Document Type: Article

References (68)

1. Principles of improved tablet production system design
2. Firm resources and sustained competitive advantage
3. Strategic groups: Untested assertions and research proposals
4. Generic knowledge strategies in the US pharmaceutical industry
5. Innovation and corporate growth in the evolution of the drug industry
6. From entry barriers to mobility barriers: Conjectural decisions and contrived deterrence to new competition
7. The challenge by domestic enterprises to the transnational corporations' domination: A case study of the Argentine pharmaceutical industry
8. Untangling the origins of competitive advantage
9. Strategic group formation and performance: The case of the US pharmaceutical industry, 1963-1982
10. Asset stock accumulation and sustainability of competitive advantage
11. The cost of innovation in the pharmaceutical industry
12. Substantive and procedural uncertainty
13. Information, knowledge, vision and theories of the firm
14. Heterogeneity within an industry
15. Measuring competence? Exploring firm effects in pharmaceutical research
16. The nature, sources, and consequences of firm differences in the early history of the semiconductor industry
17. Integration and dynamic capability: Evidence from product development in automobiles and mainframe computers
18. Entropy measure of diversification and corporate growth
19. Innovation strategy of local pharmaceutical firms in Korea: A multivariate analysis
20. Persuasion or information? The economics of prescription drug advertising
21. Uncertain imitability: An analysis of interfirm differences in efficiency under competition
22. Exploration and exploitation in organisational learning
23. Market structure, R and D and advertising in the pharmaceutical industry
24. Strategic groups: Theory, research and taxonomy
25. Bioavailability in tablet technology
26. Configurations of strategy and structure: Towards a synthesis
27. Hierarchical grouping methods and stopping rules-An evaluation
28. Economies of scale in experimentation: Knowledge and technology in pharmaceutical R and D
29. Mercado de medicamentos en España. Diseño institucional de la regulacion y de la provision publica
30. Diversification strategy, profit performance and the entropy measure
31. The structure within industries and companies performance
32. Entry decisions in the generic pharmaceutical industry
33. The supply response to shifting demand in the ethical pharmaceutical industry
34. Technology, regulation, and market structure in the modern pharmaceutical industry
35. R and D/marketing interface in a firm's capability-building process: Evidence from pharmaceutical firms